RT @ericdeinmd: #ACR21 Abs#0834: CorEvitas Registry TNFi vs IL-6 in RA âï¸IL6 pts older, longer h/o RA, higher CDAI,
Tweet Content
#ACR21 Abs#0834: CorEvitas Registry TNFi vs IL-6 in RA
⭐️IL6 pts older, longer h/o RA, higher CDAI, more prior Rx
▶️ No difference in outcomes bw IL6 and TNFi (monotherapy or combo w MTX).
▶️1/3 of pts achieved LDA
Limits: real-world, unblinded
https://t.co/AJtzeMuj1T @Rheumnow
Links
Show on Archive Page
On
Display in Search Results
On
PDQ
Off